Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden. The US organization’s main mission is to commercialize the drug Zubsolv® (buprenorphine and naloxone) sublingual tablet (CIII) for treatment of opioid dependence on the American market. Additionally, Orexo US Inc. focuses on clinical development and regulatory issues.
Orexo US Inc. Corporate Governance
For compliance issues or concerns, please submit a report via web at: www.orexo.ethicspoint.com or call +1-844-251-4251
Related US web pages:
For information on Orexo AB (publ.), please visit the corporate website www.orexo.com.